Reteplase (Reteplase)


Combined with:

Abciximab (Abciximab)
Aspirin
Clopidogrel
Heparin
Reopro
Simvastatin

Indications and Reactions:

Role Indications Reactions
Primary
Acute Myocardial Infarction 96.5%
Myocardial Infarction 2.3%
Thrombolysis 0.3%
Coronary Artery Disease 0.2%
Myocardial Ischaemia 0.2%
Pulmonary Embolism 0.2%
Diuretic Therapy 0.1%
Drug Use For Unknown Indication 0.1%
Hypertension 0.1%
Pain 0.1%
Pneumonia 0.1%
Coronary Artery Stenosis 22.4%
Ventricular Fibrillation 15.1%
Coronary Artery Disease 11.1%
Myocardial Ischaemia 6.5%
Cardiac Failure 4.8%
Thrombocytopenia 4.5%
Ventricular Tachycardia 4.3%
Ischaemia 3.4%
Pneumonia 3.1%
Gastrointestinal Haemorrhage 2.8%
Myocardial Infarction 2.8%
White Blood Cell Count Increased 2.8%
Pulmonary Oedema 2.6%
Ventricular Hypokinesia 2.6%
Vascular Pseudoaneurysm 2.3%
Ventricular Hypertrophy 2.3%
Intracardiac Thrombus 2.0%
Troponin Increased 1.7%
Coronary Artery Occlusion 1.4%
Coronary Artery Thrombosis 1.4%
Secondary
Acute Myocardial Infarction 36.4%
Myocardial Infarction 36.4%
Drug Use For Unknown Indication 27.3%
Mouth Haemorrhage 25.0%
Vascular Pseudoaneurysm 25.0%
Ventricular Fibrillation 25.0%
Vessel Puncture Site Haematoma 25.0%
Concomitant
Coronary Artery Thrombosis 100.0%
Pupils Unequal 100.0%

Drug Data